Chiesi Licenses Second Drug to GB Therapeutics
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 57 (Table of Contents)
Published: 5 Mar-2005
DOI: 10.3833/pdr.v2005.i57.711 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Chiesi Farmaceutici exclusively licensed its CHF1512/GT1512 drug to GB Therapeutics...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018